Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study

Caris Life Sciences Presents Data Demonstrating the Ability of ADAPT Biotargeting System to Identify Responders and Non-Responders in a Phase III Pancreatic Cancer Study

June 21, 2018 Leveraging ADAPT Biotargeting System would have significantly increased the probability of success Data presented at the ESMO World Congress on Gastrointestinal Cancer 2018 IRVING, Texas, June 21, 2018 /PRNewswire/ — Caris Life Sciences®, a leading innovator in molecular science focused on

Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Caris Life Sciences to Present New Molecular Findings at the 2018 ASCO Annual Meeting

Caris Data Further Advances Molecular Understandings of Cancer to Enable the Delivery of Precision Medicine IRVING, Texas, May 21, 2018 /PRNewswire/ — Caris Life Sciences®, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the acceptance